Skip to main content

Anatomische, biochemische und funktionelle Strukturen physiologischer Neurotransmitter-Regelkreise

  • Chapter
Neurotransmitter und psychische Erkrankungen

Part of the book series: Tropon-Symposium VI ((BAYERZNS,volume 6))

  • 69 Accesses

Zusammenfassung

Neuroanatomische Studien, die mit entsprechenden Tierexperimenten gekoppelt waren, sowie Untersuchungen und Beobachtungen über die Auswirkungen von Gehirnverletzungen, elektrischen Reizungen und neurochirurgischen Eingriffen führten zu einer Kartierung der Funktionen im menschlichen Gehirn. Man geht heute davon aus, daß das Gehirn sowohl fokal (also mit klar abgegrenzten Zentren) als auch diffus organisiert ist — je nachdem, welche Funktionen man untersucht (zur Übersicht: McGeer et al. 1987). Sensorische und motorische Grundfunktionen werden von sehr spezifischen Regionen kontrolliert, während die höheren geistigen Funktionen mehrere über das Gehirn verteilte Bereiche beanspruchen. Auf zellulärer und molekularer Ebene erfolgt die Informationsübertragung über ein neuronales Netzwerk mit verschiedenen Neurotransmittersystemen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366–375

    Article  PubMed  CAS  Google Scholar 

  • Albin RL, Young AB, Penney JB (1990) Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington’s disease. N Engl J Med 332:1293–1298

    Article  Google Scholar 

  • Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266–271

    Article  PubMed  CAS  Google Scholar 

  • Andersen PH, Jansen JA (1990) Dopamine receptor agonists: selectivity and dopamine Di receptor efficacy. Eur J Pharmacol 188:335–347

    Article  PubMed  CAS  Google Scholar 

  • Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 20:415–455

    Article  PubMed  CAS  Google Scholar 

  • Birkmayer W (1969) Der Alpha-Methyl-P-Tyrosin-Effekt bei extrapyramidalen Erkrankungen. Wien Klin Wochenschr 81:10–12

    PubMed  CAS  Google Scholar 

  • Burns RS, Chiueh CC, Markey SP, Eberth MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546–4550

    Article  PubMed  CAS  Google Scholar 

  • Carlsson A, Lindquist M, Magnusson T (1957) 2,3-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200

    Article  PubMed  CAS  Google Scholar 

  • Carpenter MB, Carpenter CS (1951) Analysis of somatotopic relations of the corpus Luysii in man and monkey. Relation between the site of dyskinesia and distribution of lesions within the subthalamic nucleus. J Comp Neurol 95:349–351

    CAS  Google Scholar 

  • Chevalier G, Vacher S, Deniau JM, Desban M (1985) Disinhibition as a basic process in the expression of striatal function. I. The striato-nigral influence on tecto-spinal/tecto-diencephalic neurones. Brain Res 334:215–226

    Article  PubMed  CAS  Google Scholar 

  • Crossman AR (1987) Primate models of dyskinesias: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience 21:1–40

    Article  PubMed  CAS  Google Scholar 

  • Crossman AR, Sambrook MA, Jackson AJ (1984) Experimental hemichorea/hemiballism in monkey. Brain 107:579–596

    Article  PubMed  Google Scholar 

  • Crossman AR, Mitchell IJ, Jackson AJ, Sambrook MA (1988) Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex: the site of drug action and a hypothesis of the neural mechanisms of chorea. Brain 111:1211–1233

    Article  PubMed  Google Scholar 

  • Crout JR (1961) The inhibition of catechol-O-methyltransferase by pyrogallol in the rat. Biochem Pharmacol 6:47–54

    Article  PubMed  CAS  Google Scholar 

  • Dawborn D, de Quidt ME, Emson PC (1985) Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington’s disease. Brain Res 411:251–260

    Article  Google Scholar 

  • DeLong MR, Alexander GE, Georgopoulos AP, Crutcher MD, Mitchel SJ, Richardson RT (1984) Role of basal ganglia in limb movements. Human Neurobiol 2:235–244

    CAS  Google Scholar 

  • Deniau JM, Chevalier G (1985) Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of ventromedial thalamic nucleus. Brain Res 334:227–233

    Article  PubMed  CAS  Google Scholar 

  • Ferrante RJ, Kowall NW, Beal MF, Richardson EP jr, Bird ED, Martin JB (1985) Selective sparing of a class of striatal neurons in Huntington’s disease. Science 230:561–563

    Article  PubMed  CAS  Google Scholar 

  • Filion M, Tremblay L, Bedard PJ (1988) Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys. Brain Res 444:165–176

    Article  PubMed  CAS  Google Scholar 

  • Fonnum F (1984) Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42:1–11

    Article  PubMed  CAS  Google Scholar 

  • Fonnum F, Soreide A, Kvale I, Walker J, Walaas I (1981) Glutamate in cortical fibres. In: DiChiara G, Gessa GL (eds) Glutamate as a neurotransmitter. Raven Press, New York, pp 29–41

    Google Scholar 

  • Gibb WRG, Terruli M, Lees AJ, Jenner P, Marsden CD (1989) The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Mov Disord 4:53–74

    Article  PubMed  CAS  Google Scholar 

  • Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244–254

    Article  PubMed  CAS  Google Scholar 

  • Graybiel AM, Ragsdale CW (1983) Biochemical anatomy of the striatum. In: Emson PC (ed) Chemical neuroanatomy. Raven Press, New York, pp 427–504

    Google Scholar 

  • Heidmann T, Changeux JP (1978) Structural and functional properties of the acetylcholine receptor protein in its purified and membrane-bound states. Ann Rev Biochem 47:317–357

    Article  PubMed  CAS  Google Scholar 

  • Hucho F (Hrsg) (1982) Einführung in die Neurochemie. Verlag Chemie, Weinheim

    Google Scholar 

  • Hunt P, Kannengiesser MH, Raynaud JP (1974) Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum. J Pharm Pharmacol 26:370–371

    Article  PubMed  CAS  Google Scholar 

  • Jakob H, Beckmann H (1986) Prenatal development disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65:303–326

    Article  PubMed  CAS  Google Scholar 

  • Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285–1297

    Article  PubMed  CAS  Google Scholar 

  • Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmüller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20:379–382

    Article  PubMed  CAS  Google Scholar 

  • Kinemuchi H, Fowler C, Tipton KF (1987) The neurotoxicity of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) and its relevance to Parkinson’s disease. Neurochem Int 11:359–373

    Article  PubMed  CAS  Google Scholar 

  • Kitai ST, Kita H (1987) Anatomy and physiology of the subthalamic nucleus: a driving force of the basal ganglia. In: Carpenter MM, Jayaraman A (eds) The basal ganglia II, structure and function: current concepts. Plenum Press, New York (Advances in behavioral biology, Vol 31, pp 357–373)

    Google Scholar 

  • Knoll J (1986) The pharmacology of (-)-deprenyl. J Neural Transm [Suppl] 22:75–89

    CAS  Google Scholar 

  • Kornhuber HH, Kornhuber J, Kim JS, Kornhuber ME (1984) Zur biochemischen Theorie der Schizophrenie. Nervenarzt 55:602–606

    PubMed  CAS  Google Scholar 

  • Kornhuber J, Mack-Burkhardt F, Riederer P, Hebenstreit GF, Reynolds GP, Andrews HB, Beckmann H (1989) [3H] MK-801 binding sites in postmortem brain regions of schizophrenic patients. J Neural Transm 77:231–236

    Article  PubMed  CAS  Google Scholar 

  • Lundberg JM, Hökfelt T (1983) Coexistence of peptides and classical transmitters. Trends Neurosci 6:325–333

    Article  CAS  Google Scholar 

  • Martin JB, Gusella JF (1986) Huntington’s disease: pathogenesis and management. N End J Med 315:1267–1276

    Article  CAS  Google Scholar 

  • McGeer PL, Sir Eccles JC, McGeer EG (eds) (1987) Molecular neurobiology of the mammalian brain, 2nd edn. Plenum Press, New York

    Google Scholar 

  • Miller WC, DeLong MR (1987) Altered tonic activity of neurones in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter MB, Jayaraman A (eds) The basal ganglia II, structure and function: current concepts. Plenum Press, New York (Advances in behavioral biology, Vol 32, pp 395-403)

    Google Scholar 

  • Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, Crossman AR (1989) Neural mechamisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. Neuroscience 32:213–226

    Article  PubMed  CAS  Google Scholar 

  • Mitchell PR, Doggett NS (1980) Modulation of striatal 3H-glutamic acid release by dopaminergic drugs. Life Sci 26:2073–2081

    Article  PubMed  CAS  Google Scholar 

  • Mitchell R (1987) Molecular aspects of central neurotransmitter function. In: Flückinger E, Müller E, Thorner MO (eds) Basic and clinical aspects of neuroscience, Vol 2. Springer, Berlin Heidelberg New York Tokyo, pp 1–9

    Google Scholar 

  • Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase, the initial step in norepinephrine biosynthesis. J Biol Chem 239:2910–2917

    PubMed  CAS  Google Scholar 

  • Nauta WJH, Domesick VB (1984) Afferent and efferent relationships of the basal ganglia. In: Evered D, O’Connor M (eds) Functions of the basal ganglia. Pitman, London, pp 3–23

    Google Scholar 

  • Nicoll RA, Malenka RC, Kauer JA (1990) Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol Rev 70:513–565

    PubMed  CAS  Google Scholar 

  • Nieoullon A, Kerkerian L, Dusticier N (1982) Inhibitory effects of dopamine on high affinity glutamate uptake from rat striatum. Life Sci 30:1165–1172

    Article  PubMed  CAS  Google Scholar 

  • Penney JB, Young AB (1981) GAB A as the pallidothalamic neurotransmitter: implications for basal ganglia function. Brain Res 207:195–199

    Article  PubMed  CAS  Google Scholar 

  • Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes. Annu Rev Neurosci 11:45–60

    Article  PubMed  CAS  Google Scholar 

  • Phelps PA, Houser CR, Vaughn JE (1985) Immunocytochemical localizaton of choline acetyltransferase within the rat neostriatum: a correlated light and electron microscopic study of cholinergic neurons and synapses. J Comp Neurol 238:286–307

    Article  PubMed  CAS  Google Scholar 

  • Reiner A, Albin RL, Anderson KD, D’Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington’s disease. Proc Natl Acad Sci USA 85:5733–5737

    Article  PubMed  CAS  Google Scholar 

  • Riederer P, Wuketich S (1976) Time course of nigrostriatal degeneration in Parkinson’s disease. J Neural Transm 39:277–301

    Article  Google Scholar 

  • Roos RAC (1986) Neuropathology of Huntington’s chorea. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Extrapyramidal disorders. Elsevier, New York (Handbook of clinical neurology, Vol 49, pp 315-326)

    Google Scholar 

  • Russ H, Mihatsch W, Gerlach M, Riederer P, Przuntek H (1991) Neurochemical and behavioural features induced by chronic low dose treatment with l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson’s disease. Neurosci Lett 123:115–118

    Article  PubMed  CAS  Google Scholar 

  • Schwartz WJ, Smith CB, Davidsen L, Savaki H, Sokoloff L (1979) Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science 205:723–725

    Article  PubMed  CAS  Google Scholar 

  • Smith Y, Parent A (1988) Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res 453:353–356

    Article  PubMed  CAS  Google Scholar 

  • Wagner GC, Seiden LS, Schuster CR (1979) Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. Drug Alcohol Dep 4:435–438

    Article  CAS  Google Scholar 

  • Walker FO, Young AB, Penney JB, Dorovini-Zis K, Shoulson I (1984) Benzodiazepine and GABA receptors in early Huntington’s disease. Neurology 34:1237–1240

    PubMed  CAS  Google Scholar 

  • Young AB, Penney JB (1988) Biochemical and functional organization of the basal ganglia. In: Jankovic J, Tolosa E (eds) Parkinsons’s disease and movement disorders. Urban & Schwarzenberg, München, pp 1–11

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gerlach, M., Gsell, W., Riederer, P. (1991). Anatomische, biochemische und funktionelle Strukturen physiologischer Neurotransmitter-Regelkreise. In: Beckmann, H., Osterheider, M. (eds) Neurotransmitter und psychische Erkrankungen. Tropon-Symposium VI, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84544-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84544-4_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54220-9

  • Online ISBN: 978-3-642-84544-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics